Page last updated: 2024-09-05

sorafenib and HPV Infection

sorafenib has been researched along with HPV Infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al Ghazal, A; Arndt, A; Cronauer, MV; Kraft, K; Müller, J; Schrader, AJ; Schrader, M; Skowronek, P; Steinestel, J; Steinestel, K	1

Other Studies

1 other study(ies) available for sorafenib and HPV Infection

Article	Year
Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection. PloS one, 2013, Volume: 8, Issue:5 Topics: Aged; Carcinoma in Situ; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Epithelial-Mesenchymal Transition; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Niacinamide; Papillomaviridae; Papillomavirus Infections; Phenylurea Compounds; Sorafenib; Transfection; Urokinase-Type Plasminogen Activator; Urothelium; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2013

Article

Year

Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.

PloS one, 2013, Volume: 8, Issue:5

Topics: Aged; Carcinoma in Situ; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Epithelial-Mesenchymal Transition; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Niacinamide; Papillomaviridae; Papillomavirus Infections; Phenylurea Compounds; Sorafenib; Transfection; Urokinase-Type Plasminogen Activator; Urothelium; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2013